Population
A7r5 smooth muscle cells
Comparison
Intracellular application of Angiotensin II via… vs Quiescent cells and extracellular Angiotensin II
Design
Preclinical
Authors
Loading...
Intracellular Ang II effects on VSMC growth remain preclinical; leaves open whether atypical receptors represent a human therapeutic target.
Intracellular Angiotensin II induces vascular smooth muscle cell growth through atypical AT-receptors via PI-3K and MAPK/ERK-sensitive pathways, independent of plasma membrane receptors.
Filipeanu et al. (2001) studied this question.